T1D is a heterogeneous disease, characterized by selective destruction of insulin-producing pancreatic beta cells by a yet unknown mechanism, leading to loss of insulin production and requiring a life-long daily administration of insulin. This evidence concerns the gene INS and type 1 diabetes mellitus.